Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human UBE2V1 Antibodies:
anti-Mouse (Murine) UBE2V1 Antibodies:
anti-Rat (Rattus) UBE2V1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal UBE2V1 Primary Antibody for WB - ABIN550265
Vogel, Fitzgerald, Fenton: TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. in Molecular interventions 2004
Show all 2 Pubmed References
Uev1A-Ubc13 (show UBE2N Antibodies) complex catalyzes lysine63-linked ubiquitination of RHBDF2 (show RHBDF2 Antibodies) to promote TACE (show ADAM17 Antibodies) maturation.
Uev1A appears to be involved in the BMP signaling pathway in which it collaborates with a ubiquitin E3 ligase Smurf1 (show SMURF1 Antibodies) to promote Smad1 (show GARS Antibodies) degradation in a Ubc13 (show UBE2N Antibodies)-independent manner.
variants in CD101 (show CD101 Antibodies) and UBE2V1 associated with increased risk of sexually acquired HIV-1
Gene and protein expression of UBE2v1, a ubiquitin-conjugating E2-enzyme variant that mediates Lys63-linked ubiquitination, and Lys63-ubiquitinated proteins increased in HK2 (show HK2 Antibodies) tubular cells under high glucose; immunohistochemistry on diabtic kidney samples revealed an increase in UBE2v1- and Lys63-ubiquitinated proteins, particularly in kidneys of patients with diabetic nephropathy.
Ubiquitin-conjugating enzyme (show Ube2t Antibodies) complex Uev1A-Ubc13 (show UBE2N Antibodies) promotes breast cancer metastasis through nuclear factor-small ka, CyrillicB mediated matrix metalloproteinase-1 (show MMP1 Antibodies) gene regulation.
Data demonstrate that divergent activities of Ubc13 (show UBE2N Antibodies) rely on its pairing with either of two Uevs, Uev1A or Mms2 (show UBE2V2 Antibodies).
A structural model for the Ub-hUev1a-hUbc13-Ub tetramer was developed to gain chemical insight into the synthesis of Lys(63)-linked Ubiquitin chains.
These data provide evidence that Uev1A is a critical regulatory component in the NF-kappaB (show NFKB1 Antibodies) signaling pathway in response to environmental stresses and identify UEV1A as a potential proto-oncogene (show RAB1A Antibodies).
modification of proteins with Lys(63)-linked ubiquitin chains occurs through a UEV1A-independent substrate modification and UEV1A-dependent Lys(63)-linked ubiquitin chain synthesis mechanism
work reveals that simulated microgravity promotes the apoptotic response through a combined modulation of the Uev1A/TICAM/TRAF (show TRAF1 Antibodies)/NF-kappaB (show NFKB1 Antibodies)-regulated apoptosis and the p53 (show TP53 Antibodies)/PCNA (show PCNA Antibodies)- and ATM (show ATM Antibodies)/ATR (show ATR Antibodies)-Chk1 (show CHEK1 Antibodies)/2-controlled DNA-damage response pathways.
Ubiquitin-conjugating E2 enzyme variant proteins constitute a distinct subfamily within the E2 protein family. They have sequence similarity to other ubiquitin-conjugating enzymes but lack the conserved cysteine residue that is critical for the catalytic activity of E2s. The protein encoded by this gene is located in the nucleus and can cause transcriptional activation of the human FOS proto-oncogene. It is thought to be involved in the control of differentiation by altering cell cycle behavior. Alternatively spliced transcript variants encoding multiple isoforms have been described for this gene, and multiple pseudogenes of this gene have been identified. Co-transcription of this gene and the neighboring upstream gene generates a rare transcript (Kua-UEV), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product.
ubiquitin-conjugating enzyme E2 variant 1
, DNA-binding protein
, TRAF6-regulated IKK activator 1 beta Uev1A